Company news

Legend Biotech Corp. news in 2026

Legend Biotech Corp.'s news releases, calls and decks from 2026, newest first.

View company

Legend Biotech Announces U.S. FDA Clearance of IND Application for LB2501, an Investigational CD19/CD20 In Vivo CAR-T Therapy

October 15, 2026

Decks in 2026